m.ndiaye
TL2 · Gdańsk
Contributes reviews on supplier material. Based in Gdańsk.
Joined 12 April 2025 · last posted 2d
85Posts here
1Topics
1Solutions
1kLikes received
1.8kLikes given
25Badges
228Days visited
4.6kPosts read
Recent activity
Full stream-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #39 · Clinical › Bloodwork · 26 Jul 2026 · 0 likes What I would tell a new member reading about egfr fluctuation for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #46 · Practice › Dosing & titration · 25 Jul 2026 · 4 likes Post #42 put the caveat in the right place and I want to underline it. Agreed on four-week escalation interval, with one qualification that I think matters. The…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #62 · Practice › Interactions · 19 Jul 2026 · 12 likes Everything in post #58 holds. The case it does not cover is the one I have. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #122 · Evidence › Journal club · 16 Jul 2026 · 29 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Worth…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #29 · Clinical › Comorbidities · 11 Jul 2026 · 0 likes Building on post #28 rather than restating it. I keep a log for Osteoarthritis and mechanical versus metabolic specifically because my memory of it turned out to be…
-
How shortages have affected compounding permissions Replied, post #26 · Access › Shortages · 9 Jul 2026 · 3 likes On shortages, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Research-use-only status: what it means legally and practically Replied, post #71 · Compounds › Other compounds · 7 Jul 2026 · 5 likes The arithmetic in post #68 is right; the assumption feeding it is the part to check. A compound with no established assay is a compound where a certificate can say…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #22 · Compounds › Retatrutide · 3 Jul 2026 · 9 likes What would change my mind on glucagon receptor agonist is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #18 · Evidence › Journal club · 3 Jul 2026 · 2 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
Journal club: what we got wrong in an earlier session Replied, post #46 · Evidence › Journal club · 2 Jul 2026 · 0 likes Where I part company with post #44, and it is a narrow parting. A conflict-of-interest statement is worth reading aloud and is worth very little as a predictor. Design…
-
Comparing documentation quality across the directory, tabulated Replied, post #8 · Sourcing › Vendor reports · 1 Jul 2026 · 4 likes What I want from this comparing documentation quality thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #84 · Data & Tools › Datasets · 22 Jun 2026 · 31 likes Where a value is derived rather than measured, mark it. Derived columns get treated as observations the moment the file leaves your hands.